Surgical platform UltraGreen targets Asia for growth
Singapore is not being ruled out as a potential listing location as the company seeks to tap its largest market
[SINGAPORE] Medical procedures can be risky. One company is providing data that could help reduce complications from surgery.
Now, with Singapore in the centre of its plans, UltraGreen is looking to tap the sizeable Asian market for growth.
The company’s fluorescent dye and artificial intelligence (AI) platform gives surgeons an “inside look” into living tissue, by measuring and monitoring blood flow in the human tissue.
TRENDING NOW
Think twice about rebuilding that old landed property into a super-big house to max out GFA
SpaceX’s US$1.75 trillion IPO: How retail investors, including those in Singapore, can buy shares
Yeo’s, Tiger Beer and now Gardenia – flight of food manufacturing from Singapore might be just as planned
Battle for Asia’s ultra-rich: ‘Singapore can’t afford to keep losing clients to Dubai, Hong Kong’